Wen Luo
Chief Executive Officer
Biotechnology
Denovo Biopharma
Canada
Biography
Dr. Wen Luo is the founder and CEO of a leading precision medicine company, Denovo Biopharma. Dr. Luo has 20 years of experience in biomedical research and industry including more than 10 years of experience in applying genomic technology in drug discovery and development. Prior to joining Denovo Biopharma, Dr. Luo managed the genomic group and provided bioinformatic supports to a broad range of research projects across a number of therapeutic areas including oncology, hematology, inflammation and metabolic diseases at Ligand Pharmaceuticals. He was also responsible for developing clinical biomarkers for drugs in various stages of clinical trials.
Research Interest
Bio technology,Bio pharama field,bio products
